Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant RecipientsMichael T. Ou, Jacqueline Garonzik‐Wang, Brian J. Boyarsky et al.|Transplantation|2021Cited by 88
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant RecipientsBrian J. Boyarsky, Jacqueline Garonzik‐Wang, Michael T. Ou et al.|Transplantation|2021Cited by 71
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipientsAndrew M. Hallett, Errol L. Bush, Ross S. Greenberg et al.|The Journal of Heart and Lung Transplantation|2021Cited by 65
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19Brian J. Boyarsky, William A. Werbel, Iulia Barbur et al.|Transplantation|2021Cited by 25
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myelomaRoss S. Greenberg, Philip Imus, Jake A. Ruddy et al.|BMC Cancer|2021Cited by 14